| [1] | Manolis AA, Manolis TA, Melita H, et al.  Congenital heart block: Pace earlier (Childhood) than later (Adulthood)[J]. Trends Cardiovasc Med, 2020, 30(5): 275-286. doi: 10.1016/j.tcm.2019.06.006
 | 
																													
																						| [2] | Larmay HJ, Strasburger JF. Differential diagnosis and management of the fetus and newborn with an irregular or abnormal heart rate[J]. Pediatr Clin North Am, 2004, 51(4): 1033-1050. doi: 10.1016/j.pcl.2004.03.013
 | 
																													
																						| [3] | Hansahiranwadee W. Diagnosis and management of fetal autoimmune atrioventricular block[J]. Int J Womens Health, 2020, 12: 633-639. doi: 10.2147/IJWH.S257407
																																					pmid: 32884363
 | 
																													
																						| [4] | Steinberg L. Congenital Heart Block[J]. Card Electrophysiol Clin, 2021, 13(4): 691-702. doi: 10.1016/j.ccep.2021.07.006
																																					pmid: 34689896
 | 
																													
																						| [5] | Eliasson H, Sonesson SE, Sharland G, et al.  Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients[J]. Circulation, 2011, 124(18): 1919-1926. doi: 10.1161/CIRCULATIONAHA.111.041970
																																					pmid: 21986286
 | 
																													
																						| [6] | Izmirly PM, Saxena A, Kim MY, et al.  Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus[J]. Circulation, 2011, 124(18): 1927-1935. doi: 10.1161/CIRCULATIONAHA.111.033894
																																					pmid: 21969015
 | 
																													
																						| [7] | Kuleva M, Le Bidois J, Decaudin A, et al.  Clinical course and outcome of antenatally detected atrioventricular block: experience of a single tertiary centre and review of the literature[J]. Prenat Diagn, 2015, 35(4): 354-361. doi: 10.1002/pd.4547
 | 
																													
																						| [8] | Escobar-Diaz MC, Tworetzky W, Friedman K, et al.  Perinatal outcome in fetuses with heterotaxy syndrome and atrioventricular block or bradycardia[J]. Pediatr Cardiol, 2014, 35(6): 906-913. doi: 10.1007/s00246-014-0874-x
																																					pmid: 24509635
 | 
																													
																						| [9] | Jaeggi ET, Hornberger LK, Smallhorn JF, et al.  Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature[J]. Ultrasound Obstet Gynecol, 2005, 26(1): 16-21. doi: 10.1002/uog.1919
 | 
																													
																						| [10] | Hernstadt H, Regan W, Bhatt H, et al.  Cohort study of congenital complete heart block among preterm neonates: a single-center experience over a 15-year period[J]. Eur J Pediatr, 2022, 181(3): 1047-1054. doi: 10.1007/s00431-021-04293-8
 | 
																													
																						| [11] | Ruffatti A, Cerutti A, Tonello M, et al.  Short and long-term outcomes of children with autoimmune congenital heart block treated with a combined maternal-neonatal therapy. A comparison study[J]. J Perinatol, 2022, 42(9): 1161-1168. doi: 10.1038/s41372-022-01431-4
 | 
																													
																						| [12] | Saito M, Silverman E, Golding F, et al.  Effects of transplacental dexamethasone therapy on fetal immune-mediated complete heart block[J]. Fetal Diagn Ther, 2021, 48(3): 183-188. doi: 10.1159/000513202
																																					pmid: 33592603
 | 
																													
																						| [13] | De Carolis S, Garufi C, Garufi E, et al.  Autoimmune congenital heart block: a review of biomarkers and management of pregnancy[J]. Front Pediatr, 2020, 8: 607515. doi: 10.3389/fped.2020.607515
 | 
																													
																						| [14] | Izmirly PM, Saxena A, Sahl SK, et al.  Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system[J]. Ann Rheum Dis, 2016, 75(6): 1161-1165. doi: 10.1136/annrheumdis-2015-208311
																																					pmid: 26835701
 | 
																													
																						| [15] | Epstein AE, DiMarco JP, Ellenbogen KA, et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol, 2013, 61(3): e6-75. | 
																													
																						| [16] | Kusumoto FM, Schoenfeld MH, Barrett C, et al.  2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society[J]. Heart Rhythm, 2019, 74(7): e51-e156. | 
																													
																						| [17] | Jaeggi ET, Hamilton RM, Silverman ED, et al.  Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years[J]. J Am Coll Cardiol, 2002, 39(1): 130-1387. doi: 10.1016/s0735-1097(01)01697-7
																																					pmid: 11755298
 | 
																													
																						| [18] | Michaëlsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study[J]. Circulation, 1995, 92(3): 442-449. pmid: 7634461
 |